PhenX - human papillomavirus vaccine use protocol 100801 62662-2
LOINC Code
LOINC code
62662-2
name
PhenX - human papillomavirus vaccine use protocol 100801
description
The interviewer asks the female participant whether she has ever received a human papillomavirus (HPV) vaccination. If she answers yes, the interviewer asks her age and how many shots she received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no" then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL® is also known as Silgard. European Medicines Agency. (September 25, 2009). Silgard European Public Assessment Report. Retrieved from http://www.emea.europa.eu/humandocs/Humans/EPAR/silgard/silgard.htm. Waknine, Yael. (October 2, 2006). International Approvals: Singulair and Gardasil/Silgard. Medscape Today. Retrieved from http://www.medscape.com/viewarticle/545374.
status
TRIAL
Fully-Specified Name
component
PhenX - human papillomavirus vaccine use protocol 100801
property
-
time
Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.
Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Quick, Current, Complete - www.findacode.com